Held for Sale (Tables)

9 Months Ended

Dec. 31, 2020

Discontinued Operations and Disposal Groups [Abstract]

Assets and Liabilities Held for Sale

Total assets and liabilities of the German pharmaceutical wholesale joint venture that were classified as held for sale on the Company’s consolidated balance sheet as of March 31, 2020, were as follows:

(In millions)	March 31, 2020
Assets
Current assets
Receivables, net and other current assets	$	548
Inventories, net	478
Long-term assets	88
Remeasurement of assets of business held for sale to fair value less costs to sell (1)	(272)
Total assets held for sale	$	842
Liabilities
Current liabilities
Drafts and accounts payable	$	450
Other accrued liabilities	40
Long-term liabilities	166
Total liabilities held for sale	$	656

(1)Includes the effect of approximately $3 million of favorable cumulative foreign currency translation adjustment as of March 31, 2020.